Lung Foundation Australia is proud to collaborate with world-class international and Australian speakers to deliver the Australian Lung Cancer Conference (ALCC) 2020 scientific program.

Meet our speakers long-arrow-right

Wednesday 19 February

Time Session
9:00am - 4:00pm Faculty of Radiation Oncology Lung Interest Cooperative (FROLIC) Workshop

(Dr. Louis Lao, A/Prof Gerry Hanna)

View full program. 

8:00am - 5:00pm Australia and New Zealand Lung Cancer Nurses Forum (ANZ-LCNF) Nursing and Allied Health Workshop

(Proudly Sponsored By Roche)

Session 1: Quality In Diagnostics & Care

Session 2: Hope & Equity

Session 3: Living with thoracic cancer and beyond

Session 4: Improving nurse and patient outcomes in lung cancer

View full program. 

9:30am - 5:00pm Australasian Lung Cancer Trials Group (ALTG) Clinical Development Workshop and open SAC meeting
10:00am - 3:00pm Lung Cancer Community Forum

View full program. 

Thursday 20 February

Time Session
7:00am - 8:00am Australasian Lung Cancer Trials Group MAC Meeting

(ALTG members only)

8:00am - 9:00am Opening Ceremony
9:00am - 10:00am Keynote Presentation

• International Perspectives on Hope in Lung Cancer (Dr. Marina Garassino)

• Air Quality

10:00am - 10:30am Morning Tea and Poster Presentations
10:30am - 12:30pm Palliative Care Symposium

• Introduction; cancer patients' perspectives of palliative care (Dr. Jaclyn Yoong)

• Inpatient Palliative Care Services (Dr. Michael Chapman)

• Community Palliative Care Services (Dr. Eswaran Waran)

• Early Palliative Care (Prof David Currow)

• Palliative Care Research Update (Prof Jane Phillips)

10:30am - 12:30pm Plenary - Quality in Diagnostics and Care: ‘Leaps & Bounds’ in Lung Cancer in 2020

Chairs: A/Prof Tom John

• Science & Pathology (A/Prof Marie-Liesse Labat)

• Diagnostics (Prof. Stephen Fox)

• Medical Oncology (Targeted Therapy) (Dr. Federico Cappuzzo)

• Radiation Oncology (A/Prof Gerry Hanna)

• Surgery (A/Prof Gavin Wright)

• Allied Health (Dr Lara Edbrooke)

• Nursing ( Mary Duffy, APN Lung Cancer Nurse Specialist)

• Speaker Panel

10:30am - 12:00pm Pfizer Symposium - Lung Pathology In the Era of Targeted Therapies: ROS1 Testing in Patients with Advanced Non-Small Cell Lung Cancer

(A/Prof Nick Pavlakis and A/Prof Trishe Leong)

10:30am - 12:30pm Poster Viewing
12:30pm - 1:30pm Lunch and Poster Presentations
12:30pm - 2:00pm Roche Symposium - Non-Squamous NSCLC: Selecting The Right Treatment Regimen for Each Patient

(Dr. Federico Cappuzzo – Italy)

1:30pm - 3:00pm Basic Science Symposium: Novel insights into the biology of thoracic cancers

Chairs: A/Prof Marie-Liesse Asselin-Labat and Dr. Kate Sutherland

• Dichotomising high dimensional data: exploring immune checkpoint blockade response with bulk and single cell RNA sequencing (Dr. Melvin Chin)

• Interrogating the immune microenvironment in primary lung cancer and metastases (Dr. Clare Weeden)

• Targeting epigenetic dysregulation in SWI/SNF-deficient lung adenocarcinoma (Dr. Jason Cain)

• Exploiting cell cycle-mediators to enhance chemotherapy response in non-small cell lung cancer (Dr. Mark Adams)

• Identifying therapeutic approaches to treat KEAP1-mutant lung adenocarcinoma (Dr. Sarah Best)

• Mechanisms of immune evasion in small cell lung cancer (Dr. Marian Burr)

1:30pm - 3:30pm Oral Abstract Presentations: Screening and Early Detection

• Standard Oral Presentations

1:30pm - 3:30pm Plenary - Hope & Equity: Reinventing Clinical Trials

Co-chairs A/Prof Rob Stirling and Dr. Vanessa Brunelli, Lung Cancer Research Fellow

• Real world research participation: Setting the Stage (Linnea Olsson, Consumer Advocate - by video)

• Representation of minorities in oncology clinical trials (Dr Craig Underhill)

• Debate (featuring surprise debaters!)

  o Argument: Lung cancer patients should have access to clinical trials. Relax the eligibility criteria!

  o Rebuttal: Strict criteria are crucial in clinical trials to ensure scientific purity. Do not relax the eligibility criteria!

• PROMs, PREMs and Quality: Partnering with Patients to Develop Meaningful Measures (A/Prof Rob Stirling)

• Beyond 3rd Generation: Innovation in Clinical Trials (Prof Ben Solomon)

• Speaker panel discussion: Clinical trials: “I want the future….”

1:30pm - 3:30pm Living with Thoracic Cancer and Beyond: Exercise in Lung Cancer

Chairs: Dr Lara Edbrooke and Dr Ashanya Malalasekera

• Update: Exercise Oncology Guidelines and Position Statements (Prof Rob Newton)

• Mechanisms behind the effects of exercise in lung cancer (Mr. Jin-Soo Kim)

• Prehab & Prehab Guidelines in Oncology (Prof Linda Denehy)

• Advances in evidence for exercise following surgery and for those with inoperable disease (Dr Vinicius Calvalheri)

• Models of exercise prescription and community engagement in survivorship the real-world experience (Jane Turner)

1:30pm - 3:30pm Poster Viewing
4:00pm - 6:00pm Australasian Lung Cancer Trials Group (ALTG) Clinical Trial Concepts

(all delegates welcome)

4:00pm - 5:00pm Oral Abstracts: Epidemiology
4:00pm - 5.30pm Plenary - Living with Thoracic Cancer and Beyond: Holistic Long-term Care

Chairs: Dr. Ashanya Malalasekera

• The lived experience of long-term survivors (Consumer Advocate presentation)

• Patient experience research of unmet need: the PEEK Study (Dr Catherine Holliday)

• Models of survivorship care and long-term surveillance: What works? (Dr. Joel Rhee)

• What we can learn from Palliative Care colleagues: a positive blend of Palliative Care and Survivorship (Dr. Jaclyn Yoong)

• Voluntary Assisted Dying: what you and your patients want to know (Dr. Melissa Yang, Jacqueline Lesage, Consumer Advocate)

Followed by speaker panel discussion

6:00pm - 7:30pm Merck Sharp & Dohme Symposium - Redefining Survival Expectations For Lung Cancer Patients

(Prof. Nir Peled – Israel)

7:00pm - 07:30pm Lung Foundation Australia Welcome Cocktail Reception
7:30pm - 11:00pm Lung Foundation Australia Dinner (including Lung Cancer Research Awards)

Friday 21 February

Time Session
7:00am - 9:00am Australasian Lung Cancer Trials Group (ALTG) Strategic Planning Meeting

(ALTG members only)

7:30 am - 9:00 am Bristol Myers Squibb Symposium: What is the future of immunotherapy in NSCLC?

Speaker: Prof. Michael Boyer

• What will the lung cancer population look like in the future?

• IO in early stage NSCLC

• IO in stage III NSCLC

• Overcoming IO resistance in stage IV NSCLC

Followed by speaker panel discussion

9:00am - 10:00am Keynote presentation

• Working together: The Power of a Multi-Disciplinary Approach in Lung Cancer Treatment & Care (Prof. Angela Tod - UK)

• E-cigarettes: good intentions gone awry? The Harmful Consequences (Prof. Martin Phillips)

10:00am - 10:30am Morning Tea, Poster Viewing and Presentations
10:30am - 12:30pm Oral Abstract Presentations: Medical Oncology

• Rapid Fire Group Presentations

• Standard Oral Presentations

10:30am - 12:30pm Oral Abstract Presentations: Are We Delivering Best Practice Treatment?

• Standard Oral Presentations

10:30am - 12:30pm Symposium: Borderline Inoperable Disease

(tracks: radiology / radiation oncology / surgery)

• Optimal surgical management of stage 1 disease (Dr. Stephen Barnett)

• What role for non-surgical treatment in stage 1 disease? (A/Prof Gerry Hanna)

Followed by speaker panel discussion

• Surgery in stage 3 disease: is there a role?

• Should all stage 3 disease be treated with radiation therapy treatments? (A/Prof Gerry Hanna)

Followed by speaker panel discussion

10:30am - 12:30pm Poster Viewing
10.30am - 12:30pm Plenary - Quality in Diagnostics & Care: Lung Cancer Screening in Australia

Chairs: Prof Kwun Fong and Prof Fraser Brims

• Setting the scene: The Cancer Australia Enquiry (Dr. Vivienne Milch, Cancer Australia)

• Screening and smoking cessation (Dr. Henry Marshall)

• Screening and comorbidities (A/Prof Paul Mitchell)

• Considerations in computer-aided detection, radiomics and artificial intelligence (AI) (Dr. Brendan Adler)

• Maximising uptake: the hard to reach and underserved (Dr. Niranjan Karanth)

• Looking to international efforts to drive local implementation (Prof. Nir Peled)

Followed by speaker panel discussion

12:30pm - 2:00pm AstraZeneca Symposium - Putting evidence into practice in locally advanced and metastatic NSCLC

(Dr. Marina Garassino - Milan)

12:30pm - 1:30pm Lunch and Poster Presentations
1:30pm - 3:00pm Oral Abstract Presentations: Basic Science

• Standard Oral Presentations

1:30pm - 3:00pm Oral Abstract Presentations: Data-driven quality and care

• Standard Oral Presentations

1:30pm - 3:30pm Plenary - Hope & Equity: Toward 2030 – Achieving Hope and Equity Over The Next Decade

Chairs: A/Prof Rob Stirling and Mary Duffy, APN, Lung Cancer Nurse Consultant.

• Engaging The Patient Voice (Dr. Lisa Briggs, Consumer Advocate)

• Nurse Led Models (Prof. Angela Tod – UK)

• Equity: Do We Have It? (Prof. David Ball)

• Using Health Systems Data to Drive And Monitor Change

• Learnings From The Victorian Lung Cancer Registry (A/Prof Rob Stirling)

Followed by speaker discussion panel: Blue skies; where do we want to be in 2030 and how will we get there?

1:30pm - 3:30pm Mesothelioma Proudly Sponsored by Maurice Blackburn

• Epidemiology (Prof Fraser Brims)

• Genomics and Mesothelioma (Dr. Nicola Waddell)

• Surgical Approaches To Mesothelioma (A/ Prof Gavin Wright)

• Advances In Systemic Therapy (Prof Ken O’Byrne)

• Novel Targets For Treatment (Prof Anna Nowak)

• What Role For Radiation Therapy In Mesothelioma (A/Prof Gerry Hanna)

Followed by speaker panel discussion: Are we ‘Radical’ enough in our treatment approaches to mesothelioma?”

4:00pm - 5:00pm Poster Removal
3:30pm - 4:30pm Abstract & Poster Awards

Closing Ceremony

4:30pm- 4:45pm Afternoon Tea

Program at a Glance

The ALCC program is aligned to the recommendations of Making a Lung Cancer a Fair Fight: A BluePrint for Reform report and is presented in three core streams:

  • Quality in Diagnostics and Care
  • Living with Thoracic Cancer and Beyond
  • Hope and Equity

Registration is required for sponsor symposiums and workshops (FROLIC; ANZ-LCNF; ALTG) and can be added to your single-day or full conference registration.

Consumer Advocates Lounges

A dedicated networking area will be exclusively accessible for lung cancer consumer advocates attending ALCC 2020. Located within the main conference area, you can rest, recover and catch up with friends. Light refreshments will be served throughout the day and a variety of seating and charging stations will be available.


Download Program at a Glance long-arrow-right

Endorsed by

In collaboration with

Proudly sponsored by